NCT03068416: CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy |
|
|
| Completed | 2 | 24 | Europe | CAR T cells | Uppsala University, Uppsala University Hospital, AFA Insurance | B-cell Leukemia, B-Cell Lymphoma | 08/21 | 08/21 | | |
2016-004043-36: T cell therapy for patients with leukemia or lymphoma T cellsterapi för behandling av leukemi och lymfom. |
|
|
| Not yet recruiting | 2 | 25 | Europe | 3rd generation anti-CD19 CAR T cells, 3rdCARTa19, Solution for infusion | Uppsala University, AFA Insurance AB | CD19+ B cell lymphoma or leukemia CD19+ B cells-malignitet, Leukemia and lymphoma, blood cell cancer Leukemi och lymfom, blodcancer, Diseases [C] - Cancer [C04] | | | | |
